首页> 外文期刊>South African medical journal = >Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017
【24h】

Surveillance and comparison of antimicrobial susceptibility patterns of ESKAPE organisms isolated from patients with bacteraemia in South Africa, 2016 - 2017

机译:2016-2017年南非细菌血症患者分离出的ESKAPE生物的抗菌药敏模式监测与比较

获取原文
       

摘要

BACKGROUND. In South Africa (SA), the National Department of Health has developed an Antimicrobial Resistance National Strategy Framework document to manage antimicrobial resistance (AMR). One of the strategic objectives is to optimise surveillance and early detection of AMR. At the National Institute for Communicable Diseases (NICD), an analysis of selected organisms and antimicrobial agents from both the public and the private sectors was conducted.OBJECTIVES. The relevance of surveillance for AMR is increasingly recognised in the light of global action plans to combat resistance. In this report, we present an overview of ESKAPE (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter spp.) organisms and Escherichia coli reported from public and private sector laboratories in SA for the period 2016-2017.METHODS. Antimicrobial susceptibility testing (AST) profiles on selected ESKAPE organisms and E. coli isolated from blood cultures from the public and private sectors in 2016 and 2017 were analysed. AST data were extracted from a web-based electronic platform created by the NICD. Drug-bug combinations following the World Health Organization's Global Antimicrobial Surveillance System guidelines were included in the analysis.RESULTS. A total of 28 920 ESKAPE organisms and E. coli were reported in 2016 and 32 293 in 2017 across the two health sectors. Proportions of some organisms differed between the two health sectors, such as E. coli (19% in the public sector and 36% in the private sector), A. baumannii (14% public and 4% private), P. aeruginosa (7% public and 11% private) and S. aureus (27% public and 17% private). Susceptibility data indicated changing patterns in both sectors towards an increase in non-susceptibility to carbapenems in K. pneumoniae (p0.01). However, we demonstrated an increase in susceptibility to cloxacillin in S. aureus (p0.01) in both sectors.CONCLUSIONS. The key clinically important finding is the rapidly decreasing carbapenem susceptibility among Enterobacteriaceae reported in SA, irrespective of sector. In addition, the analysis provides information that could be used to monitor the effectiveness of interventions implemented at a national level under the guidance and direction of the national AMR framework.
机译:背景。在南非(SA),国家卫生部已制定了《抗药性国家战略框架》文件,以管理抗药性(AMR)。战略目标之一是优化AMR的监视和早期检测。在国家传染病研究所(NICD),对来自公共和私营部门的选定生物体和抗菌剂进行了分析。鉴于针对抵抗的全球行动计划,越来越多的人意识到监视对AMR的重要性。在本报告中,我们概述了2016-2017年期间SA的ESKAPE(粪肠球菌,金黄色葡萄球菌,肺炎克雷伯菌,鲍曼不动杆菌,铜绿假单胞菌,肠杆菌属)生物和大肠杆菌。方法。分析了2016年和2017年从公共和私营部门的血液培养物中分离出的精选ESKAPE生物和大肠杆菌的抗菌药敏试验(AST)概况。 AST数据是从NICD创建的基于网络的电子平台中提取的。分析中包括了遵循世界卫生组织《全球抗菌素监测系统》指南的药物-细菌组合。两个卫生部门在2016年报告了28 920种ESKAPE生物和大肠杆菌,2017年报告了32 293种。两个卫生部门之间某些生物的比例有所不同,例如大肠杆菌(公共部门为19%,私营部门为36%),鲍曼不动杆菌(公共部门为14%,私营部门为4%),铜绿假单胞菌(7 %公共和11%私人)和金黄色葡萄球菌(27%公共和17%私人)。敏感性数据表明,这两个部门的模式都在发生变化,从而导致肺炎克雷伯菌对碳青霉烯类药物的不敏感性增加(p <0.01)。然而,我们证明了金黄色葡萄球菌在两个部门中对氯沙西林的敏感性均增加(p <0.01)。关键的临床重要发现是SA中报告的肠杆菌科中碳青霉烯类药物的敏感性迅速下降,而与部门无关。此外,分析还提供了可用于监测在国家抗菌药物耐药框架的指导和指导下在国家一级实施的干预措施的有效性的信息。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号